Stuart Nicklin
Professor
Department of Cardiovascular and Medical Sciences
University of Glasgow
United Kingdom
Biography
I am currently Reader in the Institute of Cardiovascular and Medical Sciences. I completed my PhD at the Bristol Heart Institute, University of Bristol working on targeting adenoviral gene transfer vectors for cardiovascular gene therapy. I then moved to post-doctoral training in the Department of Medicine and Therapeutics at the University of Glasgow. From there I was successful in securing a British Heart Foundation Intermediate Fellowship before an academic position in the BHF GCRC.Professor of Cardiovascular Molecular Therapy (Institute of Cardiovascular and Medical Sciences) and Associate (School of Medicine, Dentistry and Nursing)
Research Interest
Counter-regulatory renin angiotensin system, Gene therapy and Viral vectors
Publications
-
Nicklin, S. A. (2016) A novel mechanism of action for angiotensin-(1-7) via the angiotensin type 1 receptor. Hypertension, 68(6), pp. 1342-1343. (doi:10.1161/HYPERTENSIONAHA.116.08215) (PMID:27698064)
-
Fattah, C. et al. (2016) Gene therapy with Angiotensin-(1-9) preserves left ventricular systolic function after myocardial infarction. Journal of the American College of Cardiology, 68(24), pp. 2652-2666. (doi:10.1016/j.jacc.2016.09.946) (PMID:27978950) (PMCID:PMC5158000)
-
Lopez-Gordo, E., Doszpoly, A., Duffy, M. R., Coughlan, L., Bradshaw, A. C., White, K. M., Denby, L., Nicklin, S. A. and Baker, A. H. (2017) Defining a novel role for the coxsackie and adenovirus receptor in human adenovirus serotype 5 transduction in vitro in the presence of mouse serum. Journal of Virology, (doi:10.1128/JVI.02487-16) (PMID:28381574)
